Central African Republic vs Congo: Statin use vs. average non-HDL cholesterol levels

Central African Republic
2.8
in 2018
Congo
2.8
in 2018
Central African Republic rank
163rd
Congo rank
163rd

Statin use vs. average non-HDL cholesterol levels over time

  • Central African Republic
  • Congo
0123198019992018

How they compare

Central African Republic currently reports 2.8 against 2.8 in Congo, a difference of 0.

Across all 39 years both countries report, Congo has been ahead every year.

Central African Republic ranks 163rd and Congo ranks 163rd of 191 countries.

Congo has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Central African Republic Congo Difference Ahead
1980s 2.67 2.88 0.21 Congo
1990s 2.7 2.9 0.2 Congo
2000s 2.78 2.9 0.12 Congo
2010s 2.8 2.86 0.0556 Congo

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Central African Republic or Congo?
Central African Republic, at 2.8 against 2.8 in Congo as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Central African Republic and Congo?
0, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and Congo?
39 years are reported by both, from 1980 to 2018.
How do Central African Republic and Congo rank globally for statin use vs. average non-hdl cholesterol levels?
Central African Republic ranks 163rd and Congo ranks 163rd of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.